The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...

New research reveals that ER+ breast cancer cells acquire aggressive characteristics through direct contact with bone marrow ...

GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British ...

Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for ...

A swimmer says he was “humiliated” after being thrown out of his local pool for using a snorkel. Kiril Georgiev, 42, has been ...

The mainstay of treatment is surgery to remove the tumor, but you may also take chemotherapy and targeted therapies. Keep reading to learn more about the types of bone cancer, some of the ...

Neutrophils are the most abundant white blood cells in the human body, primarily recognized for their essential roles in fighting infections and regulating inflammation.

The paper, "Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels," appears in the Journal of Clinical Investigation. Estrogen ...

Tumor Infiltrating Lymphocytes (TIL) is under clinical development by Essen Biotech and currently in Phase II for Metastatic Breast Cancer.

like tumor necrosis factor-alpha, to facilitate the recruitment of mesenchymal stem cells (MSCs) and initiate the bone-regeneration process. This inflammation process begins immediately upon ...

In the bone-marrow specimens we noted many large cells ... that we could not classify definitely as either megakaryocytes or tumor cells. These cases are considered negative in Table 1.